Greetings from ISPOR Europe!
STRATENYM is a boutique firm comprising a global network of expert consultants, providing strategy and value in health communications for HEOR, market access, and reimbursement initiatives.
Build your brand. Reveal its value.
Why should payers reimburse your product? Why should physicians prescribe it?
- What value does your brand add to the current treatment landscape?
- What are the distinguishing features of your brand?
- Which of those do stakeholders actually care about?
Partner with STRATENYM to translate your strategy into success.
At STRATENYM, we distill product evidence into compelling value-driven content.
We have decades of experience in the pharma industry and unique expertise communicating health economics.
Recently, our consultants have helped clients with:
- Abstracts and posters/slide presentations: eg, ISPOR, ESH, ESC, ERS, CHEST, AMMI Canada
- Manuscripts published in peer-reviewed journals: eg, New England Journal of Medicine, Chest, Current Medical Research & Opinion, Journal of Managed Care and Specialty Pharmacy
- HTA dossiers: eg, NICE STA and HST submissions, Canadian submissions (CADTH CDR, pCODR, INESSS), and AMCP and BCBSA Evidence Street dossiers
Literature reviews & technical reports
- Targeted reviews on PROs, treatment landscape, and CER evidence
- Systematic Literature Reviews (SLRs) for reimbursement submissions
- BIA and CEA reports
- Value message maps, value stories, objection handlers
- Global Value Dossiers (GVDs)
- Clinical summaries
Let our industry-specific expertise drive your brand’s success in the marketplace.
Or, if you’re just curious to learn more about our work, join our mailing list or Follow us on LinkedIn.
If you’re attending the conference, come join the conversation on Twitter!
Here are our latest thoughts and Tweets: